当前位置：文档之家 › Monitoring the healing process of laser-induced microvascular lesions using optical-resolution photo

Monitoring the healing process of laser-induced microvascular lesions using optical-resolution photo

  • 格式：pdf
  • 大小：7.54 MB
  • 文档页数：7

Best Poster AwardMonitoring the Healing Process of Laser-Induced MicrovascularLesions Using Optical-Resolution Photoacoustic MicroscopySong Hu, Konstantin I. Maslov, and Lihong V. WangOptical Imaging Laboratory, Department of Biomedical Engineering, Washington University in St.Louis, St. Louis, Missouri, USA 63130ABSTRACTOptical resolution photoacoustic microscopy (OR-PAM) possesses optical resolution and reveals endogenous optical absorption contrast, promising to be a valuable tool for in vivo microvascular imaging. In laser dermatology, OR-PAM can provide fruitful structural and functional information about the targeted microvascular lesions, such as their three-dimensional (3D) morphology, precise location inside the tissue, and blood oxygenation within single vessels, which will facilitate accurate diagnosis and proper treatment. More importantly, the advantages of noninvasiveness and measurement consistency also permit OR-PAM to monitor the healing process of the laser-surgical wound noninvasively. In this work, we employed OR-PAM to monitor the healing process of microvascular lesions induced by nanosecond-pulsed laser. Our results indicate that OR-PAM could be a very useful tool in laser dermatology and laser microsurgery.Keywords: Optical-resolution photoacoustic microscopy, vascular lesion, wound healing, longitudinal monitoring.1.INTRODUCTIONCommon cutaneous vascular lesions include port wine stains, telangiectasia, capillary hemangioma and other vascular malformations. Since the laser wavelength and pulse width need to be optimized to selectively damage the targeted vascular lesions with minimum effect to the surrounding tissues1, prompt and accurate diagnosis of these lesions is essential for proper treatment. Moreover, the biological repair of such highly specific damage needs to be understood1 to fully evaluate the treatment.However, until now, there has not been a technique that could provide chronic imaging of the intact microcirculation. Interferences and side-effects due to invasive procedures and exogenous contrast agents affect the measurement accuracy and impede longitudinal studies.The advantages of photoacoustic microscopy (PAM) over traditional optical and ultrasonic imaging include primarily the detection of endogenous optical absorption contrast at ultrasonic resolutions2, 3. In PAM, a pulsed laser beam is weakly focused into the biological tissue to produce emission of ultrasonic waves due to thermal expansion of the medium caused by absorbed laser radiation. The ultrasonic waves are then detected with a focused ultrasonic transducer to form high-resolution volumetric images. Among the existing photoacoustic imaging technologies, the spatial resolutions depend almost solely on the ultrasonic parameters including the frequency and the numerical aperture (NA). For example, in the recently developed dark-field confocal PAM, a lateral resolution of 50 µm was achieved with a center frequency of 50 MHz and an NA of 0.442-4. This resolution is adequate for many biomedical applications. However, to resolve the distal functional units in the microcirculation, such as capillaries with 4-9 µm diameters, higher spatial resolution is required.If both the lateral and axial resolutions are provided ultrasonically, the imaging penetration is limited by the frequency-dependent ultrasonic attenuation in tissue. So we have developed optical-resolution photoacoustic microscopy (OR-PAM) to achieve micrometer lateral resolution by using diffraction-limited optical focusing5, 6. Although having a Photons Plus Ultrasound: Imaging and Sensing 2009, edited by Alexander A. Oraevsky, Lihong V. Wang,Proc. of SPIE Vol. 7177, 71772I · © 2009 SPIE · CCC code: 1605-7422/09/$18 · doi: 10.1117/12.809327comparable depth penetration limit with existing high-resolution optical imaging modalities (including optical confocal microscopy, two-photon microscopy, and optical coherence tomography), OR-PAM is primarily sensitive to optical absorption contrast, whereas the other modalities are dominantly sensitive to optical scattering or fluorescence contrast.2.METHODS AND MATERIALS2.1OR-PAM systemOur OR-PAM system (Fig. 1) employs optical focusing to achieve micrometer-level lateral resolution. A dye laser pumped by an Nd:YLF laser is used as the excitation source. Laser pulses (pulse duration: 7 ns) from the dye laser are spatially filtered by a 25-µm-diameter pinhole. The pinhole is then imaged to a diffraction-limited optical focal spot with a diameter of 3.7 µm by an objective lens (NA: 0.1). The laser pulse energy after the objective lens is measured to be 80 nJ. Ultrasonic focusing is achieved through a plano-concave lens (radius of curvature: 5.2 mm; aperture: 6.4 mm; NA in water: 0.46) and the ultrasonic focal diameter is 27 µm. The optical objective lens and the ultrasonic transducer are configured coaxially and confocally as shown in Fig. 1.The combination of time-resolved detection of the photoacoustic waves with a two-dimensional (2D) raster scanning along the x-y plane generates volumetric dataset, which can be viewed through direct volumetric rendering, cross-sectional (B-scan) images, or maximum amplitude projection (MAP) images.The lateral resolution and the imaging depth of the OR-PAM system were experimentally estimated to be better than 5 µm and more than 700 µm, respectively6. The axial resolution was calculated to be 15 µm based on the manufactory-specified bandwidth of the ultrasonic transducer.Water tankzx yFigure 1. Schematic of the OR-PAM system.2.2Animal preparationAll experimental animal procedures were carried out in conformance with the laboratory animal protocol approved by the School of Medicine Animal Studies Committee of Washington University in St. Louis.Nude mice (Hsd:Athymic Nude-Foxn 1NU, Harlan Co.) were used. Before imaging, the hair on the ears was gently removed with human hair-removing lotion. A dose of 87 mg/kg Ketamine and 13 mg/kg Xylazine was administered intraperitoneally to anesthetize the animal, and anesthesia was maintained throughout the experiments using an isoflurane machine (1.0-1.5% vaporized isoflurane with an airflow rate of 1 liter/min). The body temperature of the animal was maintained at 37ºC with a temperature controlled heating pad. At the end of the experiment, the animals were killed by an intraperitoneal administration of pentobarbital at a dosage of 100 mg/kg.2.3Laser induced microvascular lesionFor wound healing experiment, we randomly selected a 1-mm-by-1-mm region in a nude mouse ear via a commercial transmission-mode optical microscope, and then imaged the selected region using our OR-PAM system. After that, we maximized the output of the nanosecond pulsed laser and removed the pinhole for destruction. The central part of the selected region was scanned with the high-intensity laser beam for continuously ten minutes. The selected region was monitored right after the laser irradiation and in the subsequent four days to record the wound healing process.3.RESULTS AND DISCUSSIONPrior to performing the laser destruction, the microvasculature of the nude mouse ear was imaged in vivo noninvasively (Fig. 2). The OR-PAM image of the microvascular network in Fig. 2(B) is highly correlated with the photograph in Fig. 2(A) taken by the transmission-mode optical microscope at a 4× magnification. However, small vessels as well as capillaries are only observable to OR-PAM. The mean ratio of the photoacoustic amplitudes between the blood vessels and the background is 20:1, which demonstrates a high endogenous optical absorption contrast6. Some microvessels with diameters of ~5 µm in Fig. 2(B) are expected to be single capillaries.Throughout the whole wound healing monitoring process, 570 nm laser wavelength—a specific optical wavelength at which the molar extinction coefficients of the oxy- and deoxy-hemoglobin are equal—is selected, the photoacoustic signal represents the total hemoglobin concentration, regardless of the hemoglobin oxygenation.The duration of the laser pulses used to destruct the microvessels is ~7ns, which is much smaller than the thermal relaxation time. These short pulses generate high local peak temperature, potentially leading to intravascular cavitation from explosive vaporization that may result in vessel rupture and sequential hemorrhage7. As shown in Fig. 3, right after the laser destruction, the irradiated blood vessels were ruptured and red blood cells were popped out to form hemorrhages.After twenty-four hours, a large portion of the hemorrhage was washed out and the residual hemorrhages were cleared gradually during the sequential days.Inflammation induced vasodilation was observed one day after the injury and lasted throughout the five-day monitoring. Inflammation represents the actions of cleansing the wound of infection, releasing soluble mediators, and generating growth factors that are involved in the recruitment and activation of fibroblasts and epithelial cell to restore the damaged microcirculation8.After four days, the pulsed laser induced microvascular lesion recovered from blood coagulation and hemostasis. However, the vessel diameters were still larger than those in the normal status, which implied the presence of inflammation. This observation is in good agreement with the known physiological knowledge, which suggests a inflammatory phase of up to two weeks8.50 µmFigure 2. The healing process of a pulsed laser induced microvascular lesion—before the laser destruction. (A) The photograph taken by a commercial transmission-mode optical microscope; (B) The front-view of the 3D microvascular morphology acquired by OR-PAM at 570 nm.A B50 µmFigure 3. The healing process of a pulsed laser induced microvascular lesion—right after the laser destruction (Day 0). (A) The photograph taken by a commercial transmission-mode optical microscope; (B) The front-view of the 3D microvascular morphology acquired by OR-PAM at 570 nm.50 µmFigure 4. The healing process of a pulsed laser induced microvascular lesion—Day 1. (A) The photograph taken by a commercial transmission-mode optical microscope; (B) The front-view of the 3D microvascular morphology acquired by OR-PAM at 570 nm.A B50 µmFigure 5. The healing process of a pulsed laser induced microvascular lesion—Day 2. (A) The photograph taken by a commercial transmission-mode optical microscope; (B) The front-view of the 3D microvascular morphology acquired by OR-PAM at 570 nm.50 µmFigure 6. The healing process of a pulsed laser induced microvascular lesion—Day 3. (A) The photograph taken by a commercial transmission-mode optical microscope; (B) The front-view of the 3D microvascular morphology acquired by OR-PAM at 570 nm.A B50 µmFigure 7. The healing process of a pulsed laser induced microvascular lesion—Day 4. (A) The photograph taken by a commercial transmission-mode optical microscope; (B) The front-view of the 3D microvascular morphology acquired by OR-PAM at 570 nm.4.CONCLUSIONSThe healing process of microvascular lesions induced by a nanosecond pulsed laser was monitored longitudinally by both our OR-PAM system and a commercial transmission-mode optical microscope. Our experimental observation is in good agreement with that of the commercial transmission-mode optical microscope but provides more detailed morphological information. Moreover, our observation is confirmed by the known physiological knowledge. OR-PAM has potentially important applications in laser dermatology and laser microsurgery.ACKNOWLEDGEMENTSThis work was sponsored by National Institutes of Health grants R01 EB000712, R01 NS46214 (Bioengineering Research Partnerships), R01 EB008085, and U54 CA136398 (Network for Translational Research). L.W. has a financial interest in Endra, Inc., which, however, did not support this work.REFERENCES1. Anderson, R.R. & Parrish, J.A. Selective photothermolysis: precise microsurgery by selective absorption ofpulsed radiation. Science220, 524-527 (1983).2. Maslov, K., Stoica, G. & Wang, L.V. In vivo dark-field reflection-mode photoacoustic microscopy. Opticsletters30, 625-627 (2005).3. Zhang, H.F., Maslov, K., Stoica, G. & Wang, L.V. Functional photoacoustic microscopy for high-resolutionand noninvasive in vivo imaging. Nature biotechnology24, 848-851 (2006).4. Zhang, H.F., Maslov, K. & Wang, L.V. In vivo imaging of subcutaneous structures using functionalphotoacoustic microscopy. Nature protocols2, 797-804 (2007).5. Maslov, K., Zhang, H.F., Hu, S., & Wang, L.V. Optical-resolution confocal photoacoustic microscopy. Proc.SPIE 6856, 68561I (2008).6. Maslov, K., Zhang, H.F., Hu, S. & Wang, L.V. Optical-resolution photoacoustic microscopy for in vivoimaging of single capillaries. Optics letters33, 929-931 (2008).7. Suthamjariya, K., Farinelli, W.A., Koh, W. & Anderson, R.R. Mechanisms of microvascular response to laserpulses. The Journal of investigative dermatology122, 518-525 (2004).8. Chin, G.A., Diegelmann, R.F. & Schultz, G.S. Cellular and molecular regulation of wound healing Edn. 1st.(Talyor & Francis, Boca Raton; 2005).。

合集下载

CATIA破面修复教程名师优质资料

CATIA破面修复教程名师优质资料

CATIA Training
Foils
Healing Assistant
Version 5 Release 9 June 2002
EDU-CAT-E-HA1-FF-V5R9
Copyright DASSAULT SYSTEMES 2002
1
Course Presentation
Objectives of the course
Copyright DASSAULT SYSTEMES 2002
4
Why Do You Need Healing ?
Foreign data: IGES, STEP, CATIA V4, other
Problems linked to imported data: •accuracy uncontrolled •validity criteria different from those of V5 •data quality downgraded during transfer •user mishandling (losses, duplications, …)
• d < 0.001mm (system tolerance): edge is shared (geometrically closed) • 0.001mm < d < merging distance: edge is shared (only topologically closed) • d > merging distance : edge is not shared, boundaries remain free sides
p.4
p.5 p.6 p.9
2. Workbench presentation
CQC_Mental_Health_Act_summary_LARGE_PRINT

CQC_Mental_Health_Act_summary_LARGE_PRINT

Monitoring the use of the Mental Health Act in 2009/10A summary of CQC’s findings and recommendations from our first annual report on our monitoring of how the Act is usedIn this summary, our observations and recommendations focus on areas where improvements are needed. This reflects the purpose of our Mental Health Act visits to wards, which is to identify where the Act is not being operated correctly and where detained patients have concerns about their care and treatment. Our main findings and conclusions are as follows.Admission and detentionIn the last decade, there has been a steady decline in the number of people treated as inpatients in mental health hospitals. However, the proportion of people being treated in hospital as detained patients, rather than as informal (voluntary) patients, is growing. In 2009/10, the Act was used more than ever before. Excluding patients who were only made subject to short-term holding powers, there were 45,755 detentions during the year, involving either people admitted under detention or who were detained after being admitted to hospital.There has been a marked reduction in the number of notifications we received for young people admitted to adult psychiatric wards under the Act, especially those under 16 years of age. This suggests that mental health services are making progress with implementing national policy and legislative changes. We saw services preparing well for the legal duty – effective from April 2010 – to provide age-appropriate accommodation for patients under the age of 18. We visited some excellent child and adolescent mental health services (CAMHS) units, which had stimulating environments that enabled young people to continue their personal, social and educational development. But we raised concerns about a lack of gender separation in some CAMHS units, which was putting young people’s dignity and sexual safety at risk. We also had concerns about the treatment regimes in some eating disorders units, which appeared to restrict personal liberty more than would be the case in most other types of psychiatric unit.Many more ‘places of safety’ are now available in hospitals than was the case a few years ago. In many areas, thisseems to have reduced the use of police cells – although staff shortages have prevented access to hospital-based places of safety in some areas. We also identified some problems about the police’s arrest and assessment practices under section 136, and about the availability of forensic medical examiners with special experience in the diagnosis and treatment of mental disorder.The Mental Health Act is used less often by acute hospitals than by mental health services. We noticed that in some acute hospitals there was poor administration of the Act’s requirements, perhaps because it is being used less often and some acute providers do not have formal arrangements in place to support its use. Nevertheless, acute hospitals must comply with the Act and Code of Practice if they detain people with mental disorders under the Act, and their registration by CQC must cover this activity.Experience of detained patientsWe continued to identify problems with over-occupancy on inpatient wards – 29% of acute wards visited in 2009/10 had occupancy rates of over 100%. Often, patients who were the least unwell were being sent home or refused re-admission because there wasn’t a bed available, rather than because they did not need to be inpatients.Our Mental Health Act Commissioners often raise concerns about the low level of staff-patient interaction that they see during their visits. Lack of staff time and skills can lead to a loss of therapeutic engagement with patients, and to unnecessarily restrictive conditions of detention.Patients’ feedback suggests that hospital life is becoming much more focused on rules and security and that more acute inpatient wards are now locked wards. We have continued to voice our concern that voluntary patients in locked wards are at risk of being unlawfully deprived of their liberty.The proportion of people in low secure beds has increased significantly since 2006, both for men and, more markedly, women. We continue to find variation in low secure treatment regimes. Examples of poor practice being followed in the name of patient security included blanket measures that risked infringing human rights law, and disregard for privacy and dignity that was verging on unsafe or abusive practice.Participation and pro tecting patients’ rightsWe have seen some excellent examples where the service’s practice, systems and processes involve the patient at each stage, and where patients’ care plans are carefully tailored to their individual needs and show their recovery goals. However, we found many services that needed to substantially improve their practices. For example, staff should make sure that every detained patient is present at Care Programme Approach meetings about their care, and involved in developing their care plans instead of simply being asked to sign the completed plan. They also needed to give patients fully personalised care plans, rather thana ’template’ style plan, with their medium and long-term recovery goals clearly set out.From April 2009, primary care trusts have had a statutory duty to make sure that detained patients have access to independent mental health advocates (IMHAs), so that if they need help to understand and exercise their legal rights, it is available to them. The patient’s service is then responsible for making sure that they are aware of this support. Many IMHA services provide a valuable contribution to advocacy for detained patients. However, in a study of 311 wards, we found that 56 (18%) did not provide access to IMHA services. Further improvement is needed to ensure that all detained patients are aware of these services and have access to them.The number of applications to the Mental Health Tribunal rose sharply in 2009, with 12,122 hearings in the year, compared to an annual average of just under 10,000 since 2000. Applications by and on behalf of CTO patients havebeen a significant part of this rise, although they are less likely to succeed than applications by patients appealing against detention. Patients and staff continue to report long delays between applications to the Tribunal and the eventual hearing and, in some c ases, patients’ hearings have been postponed more than once. Many hearings are adjourned because of lack of sufficient information – often the patient’s social circumstances report, which is either not available or inadequate.Use of control and restraint, and seclusionIn 2009/10, our Commissioners visited a number of wards where the lack of a stimulating environment and activities for patients and of one-to-one time with staff, was increasingthe likelihood of incidents that called for control and restraint. We also thought that some hospitals could have been doing more to de-escalate situations before using restraint or seclusion.The Code of Practice emphasises the importance of providing support to patients after using control and restraint, seclusion or long-term segregation and of reviewing these incidents to enable staff to learn from them. The Code also requires multidisciplinary reviews while a patient is being kept in seclusion to ensure they are returned to the ward as soon as possible. Our evidence shows that these requirements are not always being met.Some forms of ‘mechanical restraint’ that appear to be quite widely used, such as supportive chairs on wards for older people, may not even be recognised as such by professional staff. We believe there is a strong argument for introducing a system of notifications about their use, as government has suggested in the past.Detained patients and consent to treatmentMany hospitals’ certified records showed that a patient had consented to treatment when it was apparent to our visiting Commissioners that they had refused to give consent or lacked the capacity to do so. This raises questions about how accurate assessments of consent are, and how often wards update them. Patients often showed a limited understanding of their treatment and said that their doctors only very briefly discussed it with them.In April 2010, CQC registered all NHS trusts in England, including the 66 NHS mental health trusts that provide specialist mental health services. Four of the mental health trusts had conditions placed on their registration, and for three of them this related to the need for improvement in their practices for assessing and recording patients’ consent to treatment.Our data from visits by second opinion appointed doctors (SOADs) show a steady increase over the last six years in the proportion of patients deemed incapable of consent, rather than capable but refusing consent – from 55% in 2004/05 to 78% in 2009/10. Black and minority ethnic patients are more likely than White patients to be deemed incapable of consent, or capable but refusing to consent. In 2009/10, about a quarter of SOAD visits resulted in changes to the patient’s treatment plan.In 2009/10, requests for a SOAD to visit detained patients to certify medication fell by around 6% compared with 2008/09. However, services’ use of urgent treatment powers to authorise medication rose significantly. In 2004/05, 6% of patients had been given medication under urgent treatmentpowers before the SOAD visit. In 2009/10, this figure had increased to 21% of patients referred for a second opinion. While some of this increase may reflect more robust data collection, it may also be the result of difficulties in arranging timely second opinion visits.There has also been a general decline in the number of requests for visits to certify use of electro-convulsive therapy (ECT) over the last five years. We were concerned to find that a third of the 1,339 patients referred for a second opinion in 2009/10 were given at least one application of ECT under urgent treatment powers before the service requested a SOAD visit.In 2009/10, we have encountered challenges in administering the SOAD service. We are now required to provide a second opinion for patients subject to community treatment orders (CTOs), the numbers of which have proved to be much higher than the Department of Health’s predictions. We have reviewed our internal systems, and are now working with the Department of Health, the Royal College of Psychiatrists, the General Medical Council and the NHS Confederation to identify ways of increasing the number of SOADs.Community treatment ordersCommunity treatment orders were introduced in November 2008, so 2009/10 was the first full year in which supervised community treatment has been implemented in England. National statistics show that 6,241 community treatment orders were made between November 2008 and the end of March 2010 – an average of 367 a month.We analysed a sample of 208 reports by our SOADs after they visited people subject to CTOs in 2009/10. Most of the patients involved had a diagnosis of schizophrenia (81%) and other psychotic disorders, and 12% had a diagnosis of mood disorders. We found that the proportion of some Black and minority ethnic patients was larger than might be expected from census findings on the detained population liable to be placed on a CTO.In addition, 30% of the patients in the sample did not have a reported history of non-compliance or disengagement with services after discharge. This may indicate that CTOs are being applied as a preventive measure for a substantial minority of CTO patients, rather than in response to past difficulties with compliance or engagement with services. This raises concerns over the potentially very broad use of the coercive powers of CTO. However, we recognise that our data is, so far, not conclusive and we will be carrying out further study of the use of CTOs.Thirty-five per cent of our sample was prescribed medication above the limits set by the British National Formulary. While for some patients there may be legitimate reasons for this practice, each case needs to be reviewed regularly to ensure that it remains appropriate for the patient.Our Commissioners’ meetings with patients have shown that their experience of being subject to a CTO is strongly influenced by how actively they were involved in planning the details of it before being discharged from hospital. Those who felt that they had been closely involved tended to view the CTO much more positively. We are concerned to find that some patients did not know or did not understand the conditions with which they were expected to comply.What happens nextConclusionsThis year, we have highlighted the need for services to develop and monitor their practices in the following areas to ensure compliance with the Mental Health Act and Code of Practice:•Assessing people for detention: not keeping medical recommendations in reserve when the assessment iscompleted and the patient has agreed to go intohospital informally, and making sure that the outcomes of the assessment are communicated to the patient. •Use of section 136: supporting the police to avoid misuse of section 136 and ensuring access to hospital-based places of safety.•Production of social circumstances reports: reviewing both the priority given to patients’ socialcircumstance reports and how they are produced; also reviewing the quality of these reports on an ongoingbasis.•Assessment and recording of patients’ capacity and consent: to ensure this is routinely done andincludes evidence of ongoing discussion with patients. •Recording episodes of control and restraint: to ensure that there is a record of the steps that havebeen taken to de-escalate a situation before otherinterventions are considered or used, and auditingthese records to inform practice development. •Carrying out duties as statutory consultees: ensuring that records are made of conversations withSOADs and indicating that patients have been informed of the outcome of second opinions.Priority areas for improvementOur findings on the experience of detained patients raise important general issues for service providers and commissioners, including how effectively providers are putting into practice the Code of Practice principles of least restriction, respect and participation. We have identified three priority areas for improvement. Service providers should take action to review and ensure progress in the following:1. Involving detained patients in their care and treatment to enhance their experience of care and promote recovery. We recommend that services focus on ensuring that they involve patients in the following key areas of service planning and delivery:•Assessment, care planning and review processes, as a basis for developing the patient’s personalised careplan.•Planning of the patient’s community treatment order, if they are subject to supervised community treatment. •Ongoing discussions with the patient as part of assessments of capacity and consent, with thesediscussions formally recorded on the patient’s care plan.•Ensuring that detained patients are aware of IMHA services and have access to information about them. •Consulting and informing detained patients about their social circumstances reports.Even within a system that restricts people’s rights because of their mental ill-health, services can and must respect andinvolve patients in their care and treatment. Our evidence shows that, in practice, involvement of patients continues to be variable. However, the positive feedback we have received from some patients shows that genuine involvement can be achieved even where people’s rights are restricted.2. Practice relating to patients’ capacity and consent, ensuring that ongoing discussions of these issues with patients are an integral part of treatment planning. The discrepancies that our visiting Commissioners often see between patients’ recorded consent and their apparent lack of capacity or refusal of consent is concerning. We have identified consent to treatment practice as an ongoing problem in many mental health services, and will be looking for evidence of improvement in 2010/11.3. Unnecessary restrictions and blanket security measures. We recognise the importance of ensuring the safety of patients, but would nevertheless urge providers to give more thought to how they can minimise restrictions on detained patients and avoid blanket measures that compromise patients’ privacy or dignity, or unnecessarily restrict their autonomy. Not only may these be counter-therapeutic, but they could also breach human rights principles and are wrong. To help reduce the chance of incidents that might lead to the use of more restrictive interventions, and to promote dignity and safety, we also emphasise the importance of a positive therapeutic environment, supported by an appropriate staffing level and skill mix.Monitoring progressWe will continue to monitor services’ progress in relation to these issues at the local level through our Commissioners’ and SOADS’ visits to services and meetings with patients. We will draw on patients’ experiences to monitor the operation of the Mental Health Act. In addition, we will use these sources of information to inform our wider monitoring of mental health services’ c ompliance with the essential standards of quality and safety that underpin registration with CQC.Where we find systemic problems that hospital managers have not adequately addressed, we may impose conditions on the provider’s registration to bring about t he change needed to improve patients’ experience of care.。

ins指南对静脉治疗的目标要求

ins指南对静脉治疗的目标要求

ins指南对静脉治疗的目标要求英文回答：The goal of intravenous therapy, as outlined in the INS guidelines, is to provide safe and effective treatment through the administration of medications, fluids, and blood products directly into the veins. This form of therapy allows for rapid absorption and immediate systemic effects, making it a crucial method for delivering critical care and maintaining patient well-being.One of the primary objectives of intravenous therapy is to ensure the correct dosage and concentration of medications or fluids are administered to the patient. This requires careful calculation and accurate preparation of the IV solution, considering factors such as the patient's weight, age, and medical condition. By adhering to the recommended guidelines, healthcare professionals can minimize the risk of medication errors and potential harm to the patient.Another important goal of intravenous therapy is to maintain the patency and integrity of the intravenous access device. This involves regular assessment of the insertion site, monitoring for signs of infection or infiltration, and ensuring proper flushing and flushing technique. By preventing complications such as catheter-related bloodstream infections or occlusions, healthcare providers can optimize the delivery of therapy and reduce the need for device replacement or reinsertion.Furthermore, the INS guidelines emphasize the importance of patient education and involvement in their own care. Patients should be informed about the purpose and potential side effects of the medications or fluids being administered intravenously. They should also be educated on how to recognize and report any complications or adverse reactions. By empowering patients to actively participate in their treatment, healthcare professionals can enhance patient satisfaction and improve overall outcomes.In addition to these objectives, the INS guidelinesalso highlight the importance of maintaining aseptic technique during the preparation and administration of intravenous therapy. This includes proper hand hygiene, use of personal protective equipment, and adherence to sterile practices. By following these guidelines, healthcare providers can minimize the risk of infection and ensure the safety of both the patient and the healthcare team.Overall, the goal of intravenous therapy, as outlinedin the INS guidelines, is to provide safe, effective, and patient-centered care. By adhering to these guidelines, healthcare professionals can optimize the delivery of therapy, minimize complications, and promote positive outcomes for their patients.中文回答：静脉治疗的目标要求是根据INS指南，通过将药物、液体和血液制品直接注入静脉，提供安全有效的治疗。

医学英语考试试题及答案

医学英语考试试题及答案

医学英语考试试题及答案一、选择题（每题1分，共10分）1. Which of the following is a common symptom of the common cold?A. FeverB. CoughC. Both A and BD. Neither A nor B2. The term "cardiology" refers to the study of which organ?A. LiverB. HeartC. LungsD. Kidneys3. What does the abbreviation "MRI" stand for?A. Magnetic Resonance ImagingB. Medical Research InstituteC. Multiple Response IndicatorD. Medical Radiology Institute4. The process of healing a wound is known as:A. InflammationB. RegenerationC. ResectionD. Reabsorption5. Which of the following is not a type of cancer?A. LeukemiaB. MelanomaC. SarcomaD. Fibromyalgia6. The term "diabetes" is related to the body's inability to:A. Excrete wasteB. Regulate blood sugar levelsC. Maintain body temperatureD. Clot blood7. The abbreviation "HIV" stands for:A. Human Immunodeficiency VirusB. High Intensity VirusC. Hemorrhagic Influenza VirusD. Hepatitis Infection Virus8. A "pathogen" is an agent that can cause:A. DiseaseB. GrowthC. RegenerationD. Immunity9. The medical term "anemia" refers to a deficiency of:A. CalciumB. IronC. Vitamin CD. Potassium10. The abbreviation "WHO" stands for:A. World Health OrganizationB. World Health OrganizationalC. World Health OperationsD. World Health Oversight答案：1. C2. B3. A4. B5. D6. B7. A8. A9. B10. A二、填空题（每空1分，共10分）1. The medical term for inflammation of the lungs is ______.答案：Pneumonia2. A person with a condition that causes excessive thirst and urination is said to have ______.答案：Diabetes3. The study of the nervous system is known as ______.答案：Neurology4. A surgical procedure to remove a diseased organ is called a/an ______.答案：Resection5. The process by which the body destroys and removes waste and foreign substances is called ______.答案：Immunity6. A medical condition characterized by high levels of fat in the blood is known as ______.答案：Hyperlipidemia7. The abbreviation for the medical term "arteriosclerosis" is ______.答案：AS8. A deficiency in the number or quality of red blood cells is referred to as ______.答案：Anemia9. The medical term for the surgical removal of a tumor is______.答案：Excision10. The study of the structure and function of the human body is called ______.答案：Anatomy三、简答题（每题5分，共20分）1. What is the difference between a virus and a bacterium?答案：A virus is a small infectious agent that can only replicate inside the living cells of an organism, while a bacterium is a single-celled microorganism that can live independently and reproduce by binary fission.2. Explain the concept of "homeostasis" in the body.答案：Homeostasis refers to the ability of an organism to maintain a constant internal environment despite changes in external conditions. This includes the regulation of body temperature, pH, and chemical composition to ensure optimal functioning of cells and organs.3. What is the role of the thyroid gland in the body?答案：The thyroid gland is an endocrine gland that produces hormones, such as thyroxine (T4) andtriiodothyronine (T3), which regulate the body's metabolism, growth, and development.4. Describe the function of the respiratory system.答案：The respiratory system is responsible for the exchange of gases, primarily oxygen and carbon dioxide, between the body and the environment. It includes the process of inhalation, where oxygen is taken in, and exhalation, where carbon dioxide is expelled.四、翻译题（每题5分，共20分）1. 请将以下医学术语翻译成中文："Cardiopulmonary resuscitation"答案：心肺复苏2. 请将。